The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.
Open accessAbstract
Macrophages are induced by LPS to release a number of products that determine the host response during gram negative sepsis. To examine the role of one such substance, tumor necrosis factor (TNF), in mediating LPS-induced injury, we employed a rabbit model of endotoxic shock to (a) determine the kinetics and extent of release of TNF into plasma after injection of LPS, and (b) to evaluate the protective effect of in vivo neutralization of LPS-induced TNF by prior infusion of anti-TNF antibody. TNF was maximally induced 45-100 min after injection of 10 micrograms i.v. parent Salmonella minnesota Re595 LPS or 250 micrograms Re595 LPS-HDL complexes. Maximal induction of TNF by LPS was associated with development of hypotension, focal hepatic necrosis, intravascular fibrin deposition and lethality. Based on (a) the peak levels of TNF observed in serum, 2.5 X 10(3) U/ml, (b) the specific activity of purified rabbit macrophage-derived TNF, 1 X 10(8) U/mg, and (c) the biphasic disappearance of intravenously injected purified TNF (t1/2 = 0.5 min, 11 min) we constructed a kinetic model showing that at least 130 micrograms of TNF (1.3 X 10(7) U) was released into plasma 30-200 min postinjection of LPS. Prior infusion of anti-TNF antibody (30-45 min before LPS injection) resulted in neutralization of the LPS-induced serum TNF activity and provided significant protection from the development of hypotension, fibrin deposition, and lethality. Thus, these results provide further evidence that TNF plays a central role mediating the pathophysiologic changes that occur during gram negative endotoxic shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Fraker, P. J., & Speck, J. C. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91322-0 · Cited by 4,558
Silver staining of proteins in polyacrylamide gels
Wray, W., Boulikas, T., Wray, V. P., & Hancock, R. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90179-2 · Cited by 3,504
Secretory products of macrophages.
Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Beutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
A New Method for the Extraction of R Lipopolysaccharides
Galanos, C., Lüderitz, O., & Westphal, O. (1969) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1969.tb00601.x · Cited by 1,859
Cachectin and tumour necrosis factor as two sides of the same biological coin
Beutler, B., & Cerami, A. (1986) · Nature · doi:10.1038/320584a0 · Cited by 1,647
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
Cachectin: More Than a Tumor Necrosis Factor
Epstein, F. H., Beutler, B., & Cerami, A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160705 · Cited by 1,432
Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
Nawroth, P. P., & Stern, D. M. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.3.740 · Cited by 1,311
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J., Ulevitch, R., & Cerami, A. (1985) · Nature · doi:10.1038/316552a0 · Cited by 1,131
Self-citationWaage, A., Halstensen, A., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,096
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,067
Gamble, J. R., Harlan, J. M., Klebanoff, S. J., & Vadas, M. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8667 · Cited by 1,033
Human tumor necrosis factor. Production, purification, and characterization.
Aggarwal, B. B., Kohr, W. J., Hass, P. E., Moffat, B., Spencer, S. A., Henzel, W. J., Bringman, T. S., Nedwin, G. E., Goeddel, D. V., & Harkins, R. N. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89560-6 · Cited by 921
Stimulation of neutrophils by tumor necrosis factor.
Klebanoff, S. J., Vadas, M. A., Harlan, J. M., Sparks, L. H., Gamble, J. R., Agosti, J. M., & Waltersdorph, A. M. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.4220 · Cited by 832
Beutler, B., Mahoney, J., Le Trang, N., Pekala, P., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.984 · Cited by 821
Platelet Sequestration in Man. I. Methods*
Aster, R. H., & Jandl, J. H. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104970 · Cited by 816
Philip, R., & Epstein, L. B. (1986) · Nature · doi:10.1038/323086a0 · Cited by 767
Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.
Beutler, B. A., Milsark, I. W., & Cerami, A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3972 · Cited by 763
Nawroth, P. P., Bank, I., Handley, D., Cassimeris, J., Chess, L., & Stern, D. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1363 · Cited by 693
The effects of bacterial endotoxins on host mediation systems. A review.
Morrison, D. C., & Ulevitch, R. J. (1978) · PubMed · Cited by 649
Self-citationPohlman, T. H., Stanness, K. A., Beatty, P. G., Ochs, H. D., & Harlan, J. M. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.12.4548 · Cited by 588
Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.
Tobias, P. S., Soldau, K., & Ulevitch, R. J. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.3.777 · Cited by 541
Self-citationRAISED SERUM LEVELS OF TUMOUR NECROSIS FACTOR IN PARASITIC INFECTIONS
Scuderi, P., Lam, K., Ryan, K., Petersen, E., Sterling, K., Finley, P., Ray, C. G., Slymen, D., & Salmon, S. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92007-6 · Cited by 458
The active form of tumor necrosis factor is a trimer.
Smith, R. A., & Baglioni, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48183-5 · Cited by 429
Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.
Tracey, K. J., Lowry, S. F., Fahey, T. J., Albert, J. D., Fong, Y., HESSE, D. G., Beutler, B., Manogue, K. R., Calvano, S. E., & Hu, W. M. (1987) · PubMed · Cited by 429
Mathison, J. C., & Ulevitch, R. J. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.5.2133 · Cited by 422
Self-citationStolpen, A. H., Guinan, E. C., Fiers, W. C., & Pober, J. S. (1986) · PubMed Central · Cited by 401
Purification and physico-chemical characterization of rabbit tumor necrosis factor.
Ruff, M. R., & Gifford, G. E. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.4.1671 · Cited by 385
The fate of interleukin-2 after in vivo administration.
Donohue, J. H., & Rosenberg, S. A. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.5.2203 · Cited by 375
Human interleukin 1 is a cytocidal factor for several tumor cell lines.
Onozaki, K., Matsushima, K., Aggarwal, B. B., & Oppenheim, J. J. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3962 · Cited by 372
Mechanisms of the Hemodynamic Effects of Endotoxin
Gilbert, R. P. (1960) · Physiological Reviews · doi:10.1152/physrev.1960.40.2.245 · Cited by 355
Bachwich, P. R., Chensue, S. W., Larrick, J. W., & Kunkel, S. L. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90881-8 · Cited by 337
Freudenberg, M. A., Keppler, D., & Galanos, C. (1986) · Infection and Immunity · doi:10.1128/iai.51.3.891-895.1986 · Cited by 333
Tumor necrosis factor provokes superoxide anion generation from neutrophils
Tsujimoto, M., Yokota, S., Vilček, J., & Weissmann, G. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90337-2 · Cited by 301
Ulevitch, R. J., Johnston, A. R., & Weinstein, D. B. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109610 · Cited by 290
Self-citationAsher, A., Mulé, J. J., Reichert, C. M., Shiloni, E., & Rosenberg, S. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.963 · Cited by 289
Kettelhut, I. C., Fiers, W., & Goldberg, A. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.12.4273 · Cited by 286
Acute in vivo effects of human recombinant tumor necrosis factor.
Remick, D. G., Kunkel, R. G., Larrick, J. W., & Kunkel, S. L. (1987) · PubMed · Cited by 256
Receptor Binding and Activation of Polymorphonuclear Neutrophils by Tumor Necrosis Factor-Alpha
Shalaby, M. R., Palladino, M. A., Hirabayashi, S. E., Eessalu, T. E., Lewis, G. D., Shepard, H. M., & Aggarwal, B. B. (1987) · Journal of Leukocyte Biology · doi:10.1002/jlb.41.3.196 · Cited by 216
Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential.
Tracey, K. J., Lowry, S. F., Beutler, B., Cerami, A., Albert, J. D., & Shires, G. T. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.4.1368 · Cited by 171
Bacterial Endotoxins (Part 1 of 2)
Westphal, O. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000231374 · Cited by 155
The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum.
Ulevitch, R. J., & Johnston, A. R. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109252 · Cited by 152
Self-citationInteraction of lipopolysaccharides with plasma high-density lipoprotein in rats
Freudenberg, M. A., Bøg-Hansen, T. C., Back, U., & Galanos, C. (1980) · Infection and Immunity · doi:10.1128/iai.28.2.373-380.1980 · Cited by 146
Waage, A., Espevik, T., & Lamvik, J. O. (1986) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1986.tb02194.x · Cited by 129
Munford, R. S., Hall, C. L., Lipton, J. M., & Dietschy, J. M. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110684 · Cited by 122
Munford, R. S., Andersen, J. M., & Dietschy, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110404 · Cited by 111
Rubin, B. Y., Anderson, S. L., Sullivan, S. A., Williamson, B., Carswell, E. A., & Old, L. J. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.4.1350 · Cited by 108
In vitro production of rabbit macrophage tumor cell cytotoxin
Fisch, H., & Gifford, G. E. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910320117 · Cited by 82
Pharmacokinetics of Murine Tumor Necrosis Factor
Flick, D. A., & Glfford, G. E. (1986) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923978609031087 · Cited by 55
Significant contribution of spleen cells in mediating the lethal effects of endotoxin in vivo
Glodé, L. M., Mergenhagen, S. E., & Rosenstreich, D. L. (1976) · Infection and Immunity · doi:10.1128/iai.14.3.626-630.1976 · Cited by 52
Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s).
Tobias, P. S., & Ulevitch, R. J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.4.1913 · Cited by 46
Self-citation
Cited by
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
Self-citationThe clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
Structure and Function of Lipopolysaccharide Binding Protein
Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., & Ulevitch, R. J. (1990) · Science · doi:10.1126/science.2402637 · Cited by 1,672
Self-citationInterleukin-1 and Its Biologically Related Cytokines
Dinarello, C. A. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60642-2 · Cited by 1,151
Tumor necrosis factor: a pleiotropic cytokine and therapuetic target
Tracey, M. D., & Cerami, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.491 · Cited by 1,063
Metadata
- Authors
- Mathison, J. C., Wolfson, E., & Ulevitch, R. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1988-06-01
- Volume
- 81
- Issue
- 6
- Pages
- 1925-1937
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2107907376
- Cited by
- 591
- References
- 56
- FWCI
- 45.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.